Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

431 trials

NCT07493629
Recruiting
Immune Status and Disease Control of Inflammatory Airway Diseases
Not applicable · China · 1 site
Registry update: 25 Mar 2026
NCT07039669
Recruiting
Evaluation of 611 in Chinese Adults Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Phase 3 · China · 4 sites
Registry update: 18 Nov 2025
NCT07292714
Recruiting
A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Phase 2 · China · 50 sites
Registry update: 18 Dec 2025
NCT07482475
Recruiting
University of Michigan COPD Identification Through Lung Cancer Screening Cohort Study - MAP2
Not applicable · United States · 1 site
Registry update: 25 Mar 2026
NCT06891755
Recruiting
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Not applicable · Austria, Germany, United Kingdom, Netherlands, United States · 23 sites
Registry update: 19 Oct 2026
NCT07045948
Recruiting
Biannual Review of Exhaled Air and Trends in Health Evaluation in COPD
Not applicable · Belgium · 1 site
Registry update: 11 Sept 2025
NCT07387432
Recruiting
Role of Exercise in PRISm and Subsequent Development of COPD
Not applicable · China · 1 site
Registry update: 6 Mar 2026
NCT07114120
Recruiting
Clinical Study on the Treatment of Stable Bronchiectasis With Bailing Capsules Combined With Guben Kechuan Granules
Phase 4 · China · 5 sites
Registry update: 11 Aug 2025
NCT07015216
Recruiting
Effects of Virtual Reality-Assisted Dual Task Training on Muscle Oxygenation in Patients With COPD
Not applicable · 1 site
Registry update: 22 Jun 2025
NCT06862206
Recruiting
This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab
Not applicable · China · 36 sites
Registry update: 22 Jul 2026
NCT07097896
Recruiting
Endobronchial Silicone Valve for Patients With Emphysema
Not applicable · China · 1 site
Registry update: 8 Jul 2026
NCT07076667
Recruiting
Effects of Benson's Relaxation and Tai Chi in COPD
Not applicable · Pakistan · 1 site
Registry update: 22 Jul 2025
NCT07050823
Recruiting
Mitigating Chronic Respiratory Disease Through the Lens of Multi-Morbidity
Not applicable · Brazil · 2 sites
Registry update: 25 Jul 2025
NCT07052396
Recruiting
Study to Evaluate Long-term Effectiveness and Safety, Patient Characteristics and Subjective Patient-reported Outcomes of Dupilumab in Patients With Chronic Obstructive Pulmonary Disease (COPD) Under Real-world Conditions
Not applicable · Germany · 18 sites
Registry update: 22 Dec 2025
NCT06782724
Recruiting
Psilocybin Therapy for Psychological Distress in Palliative Patients
Phase 2 · Czechia, Denmark, Netherlands, Portugal · 4 sites
Registry update: 8 May 2026
NCT06958666
Recruiting
Effectiveness of DITM Versus IMT in COPD Patients
Not applicable · China · 9 sites
Registry update: 24 Jul 2026
NCT07082738
Recruiting
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Phase 2 · Argentina, Australia, Bulgaria, Canada, Chile, China, Germany, Denmark, Spain, United Kingdom, Greece, Hungary, India, Italy, Japan, South Korea, Mexico, Peru, Poland, Taiwan, Ukraine, United States, Vietnam · 300 sites
Registry update: 23 Oct 2026
NCT06961214
Recruiting
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Phase 3 · Argentina, Austria, Australia, Bulgaria, Czechia, Germany, United Kingdom, Greece, Israel, Italy, South Korea, Latvia, New Zealand, Romania, Thailand, United States · 174 sites
Registry update: 5 Oct 2026
NCT07022704
Recruiting
Doxapram Administration on Diaphragmatic Excursion in Mechanically Ventilated Patients With Chronic Obstructive Pulmonary Disease Undergoing Spontaneous Breathing Trial
Not applicable · Egypt · 1 site
Registry update: 26 Jun 2025
NCT06959095
Recruiting
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
Phase 3 · Argentina, Belgium, Canada, Switzerland, Chile, China, Germany, Denmark, Spain, France, Croatia, Hungary, Ireland, Japan, Netherlands, Norway, Poland, Portugal, Sweden, Slovakia, Taiwan, United States · 246 sites
Registry update: 5 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.